{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:12:04Z","timestamp":1792012324212,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.4065\/80.4.470","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:26:10Z","timestamp":1232760370000},"page":"470-479","source":"Crossref","is-referenced-by-count":50,"title":["Evaluation of the Comparative Efficacy of Etoricoxib and Ibuprofen for Treatment of Patients With Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.4065","volume":"80","author":[{"given":"Craig W.","family":"Wiesenhutter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Boice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret A.","family":"Wittmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Aversano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alise S.","family":"Reicin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/80.4.470_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the Unites States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.4065\/80.4.470_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2105\/AJPH.84.3.351","article-title":"The effects of specific medical conditions on the functional limitations of elders in the Framingham Study","volume":"84","author":"Guccione","year":"1994","journal-title":"Am J Public Health"},{"issue":"suppl 1","key":"10.4065\/80.4.470_bib3","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/keh102","article-title":"Osteoarthritis\u2014the impact of a serious disease","volume":"43","author":"Breedveld","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.4065\/80.4.470_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-133-8-200010170-00016","article-title":"Osteoarthritis: new insights, part 1: the disease and its risk factors","volume":"133","author":"Felson","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.4065\/80.4.470_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/ard.2003.008136","article-title":"High prevalence of osteoarthritis 14 years after an anterior cruciate ligament tear in male soccer players: a study of radiographic and patient relevant outcomes","volume":"63","author":"von Porat","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.4065\/80.4.470_bib6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jama.286.10.1195","article-title":"The continuing epidemics of obesity and diabetes in the United States","volume":"286","author":"Mokdad","year":"2001","journal-title":"JAMA"},{"key":"10.4065\/80.4.470_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0950-3579(97)80003-9","article-title":"Understanding the relationship between body weight and osteoarthritis","volume":"11","author":"Felson","year":"1997","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.4065\/80.4.470_bib8","first-page":"646","article-title":"Burden of major musculoskeletal conditions","volume":"81","author":"Woolf","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.4065\/80.4.470_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-133-9-200011070-00015","article-title":"Osteoarthritis: new insights, part 2: treatment approaches","volume":"133","author":"Felson","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.4065\/80.4.470_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004257","article-title":"Acetaminophen for osteoarthritis","volume":"2","author":"Towheed","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4065\/80.4.470_bib11","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee","volume":"43","author":"American College of Rheumatology Subcommittee on Osteoarthritis Guidelines","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.4065\/80.4.470_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI119280","article-title":"Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: influence of nitric oxide","volume":"99","author":"Amin","year":"1997","journal-title":"J Clin Invest"},{"key":"10.4065\/80.4.470_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0049-0172(03)00134-3","article-title":"Cyclooxygenase-2 and prostaglandins in articular tissues","volume":"33","author":"Martel-Pelletier","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.4065\/80.4.470_bib14","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs [published correction appears in N Engl J Med. 1999;341:548]","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4065\/80.4.470_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2036.2003.01407.x","article-title":"Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib","volume":"17","author":"Hunt","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.4065\/80.4.470_bib16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1572-0241.2003.07598.x","article-title":"The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events","volume":"98","author":"Hunt","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.4065\/80.4.470_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1358\/dot.2004.40.5.850488","article-title":"Etoricoxib","volume":"40","author":"Matsumoto","year":"2004","journal-title":"Drugs Today (Barc)"},{"key":"10.4065\/80.4.470_bib18","unstructured":"Bellamy N. WOMAC Osteoarthritis Index User Guide. Version V. Brisbane, Australia; 2002."},{"key":"10.4065\/80.4.470_bib19","first-page":"2473","article-title":"WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire [editorial]","volume":"29","author":"Bellamy","year":"2002","journal-title":"J Rheumatol"},{"key":"10.4065\/80.4.470_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1063-4584(05)80101-3","article-title":"Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society: results of a workshop","volume":"4","author":"Altman","year":"1996","journal-title":"Osteoarthritis Cartilage"},{"key":"10.4065\/80.4.470_bib21","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/rheumatology\/41.9.1052","article-title":"Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis [published correction appears in Rheumatology (Oxford). 2003; 42:814]","volume":"41","author":"Gottesdiener","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.4065\/80.4.470_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1185\/030079902125000282","article-title":"Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: a randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial","volume":"18","author":"Leung","year":"2002","journal-title":"Curr Med Res Opin"},{"issue":"9, suppl","key":"10.4065\/80.4.470_bib23","first-page":"S135","article-title":"Treatment with etoricoxib, a COX-2 selective inhibitor, resulted in clinical improvement in knee and hip osteoarthritis (OA) over 52 weeks [abstract]","volume":"44","author":"Fisher","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.4065\/80.4.470_bib24","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/archinte.160.12.1781","article-title":"A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis","volume":"160","author":"Day","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.4065\/80.4.470_bib25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archfami.9.10.1124","article-title":"Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis","volume":"9","author":"Saag","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.4065\/80.4.470_bib26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.4780110807","article-title":"Comparisons between a new drug and active and placebo controls in an efficacy clinical trial","volume":"11","author":"Dunnett","year":"1992","journal-title":"Stat Med"},{"key":"10.4065\/80.4.470_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard.2004.022905","article-title":"Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement","volume":"64","author":"Tubach","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.4065\/80.4.470_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0091270003251122","article-title":"Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man","volume":"43","author":"Agrawal","year":"2003","journal-title":"J Clin Pharamacol"},{"key":"10.4065\/80.4.470_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000046212","article-title":"Renal effects of COX-2-selective inhibitors","volume":"21","author":"Brater","year":"2001","journal-title":"Am J Nephrol"},{"issue":"15, suppl","key":"10.4065\/80.4.470_bib30","first-page":"S383","article-title":"Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey","volume":"8","author":"Singh","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.4065\/80.4.470_bib31","unstructured":"Bresalier R, Reicin A. Rofecoxib APPROVe study results and their implications. Presented at: American College of Rheumatology Annual Scientific Meeting; San Antonio, Tex; October 18, 2004."},{"key":"10.4065\/80.4.470_bib32","author":"National Cancer Institute"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611631972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611631972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T08:22:00Z","timestamp":1545466920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611631972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0025619611631972"],"URL":"https:\/\/doi.org\/10.4065\/80.4.470","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}